Events

Join us for a journal club presented by Matt Nizamoglu, PhD who will discuss a publication on “Three dimensional fibrotic extracellular matrix directs microenvironment fiber remodeling by fibroblasts” in Acta Biomaterialia. We will be joined by discussion panelists; Amanda Tatler, PhD (University of Nottingham) and Daniel Weiss, MD, PhD (University of Vermont).

A panel will discuss this recently published article and the importance of characterizing asthma endotypes based on T cell subtypes in diverse groups to aide in the development of effective therapies for youths with asthma.

Members of the CC ECPWG will host an open house for ATS attendees to discuss networking strategies, poster preparation, elevator pitches, and strategies to get the most benefit from attending the ATS national meeting.

This webinar will feature the lead authors from the recently published ATS Official Research Statement on Lung Cancer Screening Incidental Findings and will focus on knowledge and research gaps identified for this topic.

This will be a journal club discussing a study showing that glucocorticoids reprogram the mitochondrial metabolism of macrophages resulting in increased and sustained production of the anti-inflammatory metabolite itaconate and inhibition of the inflammatory response.

This conference aims to provide international knowledge for local doctors.

The ECBIP stands as a pinnacle gathering for professionals, researchers, and leaders in the field of interventional pulmonology (IP) and respiratory medicine.

The ATS International Conference is the home of pulmonary, critical care, and sleep professionals, from those in the earliest stages of their careers to those whose research or strides in clinical care has gained them international recognition.

With an emphasis on the integration of basic, translational and clinical approaches, the 67th Annual Aspen Lung Conference will focus on a central question: Are current advancements in understanding the mechanisms of lung parenchymal destruction sufficient to develop effective strategies for the early identification and treatment of emphysema and rare lung diseases with a shared phenotype?

ATS Partner Grants support targeted and disease-specific research, in collaboration with our program partners.